Industry Projects
Our project area provides a repository of past, present and future projects within the industry. As well as providing an overview of the changing market landscape, this section offers access to the suppliers involved in each project.Latest Industry Projects
Simbrinza (brinzolamide/brimonidine tartrate) is a carbonic anhydrase inhibitor developed by Alcon, a division of... > read more
Oxytrol (oxybutynin) for the Treatment of Overactive Bladder (OAB) in Women, United States of America
Oxytrol (oxybutynin) is a transdermal patch indicated for the treatment of overactive bladder in women who have symptoms of urge urinary incontinence, urgency and frequency....
Oxytrol (oxybutynin) is a transdermal patch indicated for the treatment of overactive bladder in women who have symptoms of urge urinary incontinence, urgency and frequency....
Zytiga (abiraterone acetate) - Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC), United States of America
Developed by Coughar Biotechnology, abiraterone acetate (CB7630) was discovered by the UK Institute for Cancer Research....
Developed by Coughar Biotechnology, abiraterone acetate (CB7630) was discovered by the UK Institute for Cancer Research....
Korlym (Mifepristone) for Treatment of Endogenous Cushing’s Syndrome, United States of America
Korlym (mifepristone) is a glucocorticoid receptor blocker indicated for the control of high blood sugar levels in adult patients suffering from endogenous Cushing's syndrome....
Korlym (mifepristone) is a glucocorticoid receptor blocker indicated for the control of high blood sugar levels in adult patients suffering from endogenous Cushing's syndrome....
Elelyso (Taliglucerase Alfa) for Treating Gaucher Disease, United States of America
Elelyso (taliglucerase alfa) is an intravenous drug indicated for the treatment of type one Gaucher disease. The drug was jointly developed by Protalix BioTherapeutics and...
Elelyso (taliglucerase alfa) is an intravenous drug indicated for the treatment of type one Gaucher disease. The drug was jointly developed by Protalix BioTherapeutics and...
Stivarga (Regorafenib) for Treating Metastatic Colorectal Cancer (mCRC), United States of America
Stivarga (regorafenib), developed by Bayer HealthCare, is an oral multikinase inhibitor indicated for the treatment of metastatic colorectal cancer (mCRC). The US Food and Drug Administration...
Stivarga (regorafenib), developed by Bayer HealthCare, is an oral multikinase inhibitor indicated for the treatment of metastatic colorectal cancer (mCRC). The US Food and Drug Administration...
All Projects Alphabetically
- Abatacept (Orencia) - Treatment for Rheumatoid Arthritis (RA)
- ACE-031 for the Treatment of Duchenne Muscular Dystrophy, United States of America
- Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
- Actemra - Biological Therapy for Rheumatoid Arthritis
- Actonel (Risedronate Sodium) - Treatment for Osteoporosis, United States of America
- Adcetris - Treatment for Relapsed or Refractory Hodgkin's Lymphoma
- Afamelanotide, Photo-Protective Drug
- Afinitor – Anti-Cancer Therapy
- Alemtuzumab – Potential in Multiple Sclerosis
- Almorexant
- AM103
- AMR101 – Omega-3-Based Treatment for Hypertriglyceridaemia, United Kingdom
- AN2728 for the Treatment of Psoriasis, United States of America
- Anacetrapib - Treatment for Atherosclerosis
- APD125 - Therapy for Insomnia
- Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for
- ASA404 Vascular Disrupting Agent for Solid Tumours
- AstraZeneca's Brilinta - Treatment for Acute Coronary Syndrome
- Aubagio (Teriflunomide) for the Treatment of Multiple Sclerosis, United States of America
- Avastin (bevacizumab) - Angiogenesis
- Axitinib – Treatment for Advanced Renal Cell Carcinoma
- Banzel – Treatment for Lennox-Gastaut syndrome
- Benlysta - Lupus Treatment
- Bexsero – Treatment for Meningococcal Disease
- BG-12 (Dimethyl Fumarate), Treatment for Relapsing-Remitting Multiple Sclerosis (RRMS), United States of America
- Bifeprunox - Atypical Antipsychotic Drug
- Blinatumomab
- BNC105
- Boceprevir
- Boostrix – Vaccine for Whooping Cough, Tetanus and Diphtheria, United States of America
- Bosulif (bosutinib) - Chronic Myelogenous Leukaemia (CML) Treatment, United States of America
- Byetta - First-in-Class Incretin Mimetic
- Cabozantinib
- Caprospinol, Therapy for Alzheimer's Disease (AD)
- Ceftobiprole
- Celvapan – H1N1 Pandemic Influenza Vaccine
- Cepheid Xpert vanA Test Kit, United States of America
- Cerovive - Neuroprotectant for the
- Cervarix – Cervical Cancer Vaccine
- Cetilistat - Investigational Drug for Obesity, Japan
- Cilansetron - New Treatment for IBS
- Contrave for the Treatment of Obesity, United States of America
- Corifact – Treatment for Rare Form of Haemophilia
- Cuvposa - Treatment for Chronic Drooling
- CXL-1020 Treatment for Patients with Acute Decompensated Heart Failure (ADHF), United States of America
- Cymbalta (Duloxetine HCl) for Chronic Musculoskeletal Pain Management, United States of America
- Cystaran (cysteamine hydrochloride) for Treatment of Cystinosis, United States of America
- Dalbavancin - Second-Generation Glycopeptide
- Daliresp (Roflumilast), Treatment to Reduce COPD, United States of America
- Darapladib - Selective Lp-PLA2 Inhibitor for Prevention of Atherosclerosis
- Dasatinib - Tyrosine Kinase Inhibitor for Chronic
- Dimebon - Investigational Compound Indicated for the Treatment of Alzheimer's and Huntington's Disease, United States of America
- Doripenem - A New Broad-Spectrum Carabapenem Antibiotic
- Dulera (Mometasone Furoate and Formoterol Fumarate Dihydrate) - Treatment for Asthma, United States of America
- Edarbi for the Treatment of Hypertension, United States of America
- Edoxaban, Oral Anticoagulant, Japan
- Elacytarabine (CP-4055) for Treatment of Acute Myeloid Leukaemia, United States of America
- Elelyso (Taliglucerase Alfa) for Treating Gaucher Disease, United States of America
- Eliquis (apixaban) for Prevention of Stroke in Nonvalvular Atrial Fibrillation (NVAF) Patients
- Elotuzumab
- Enbrel – Immunosuppressant for Treatment of Rheumatoid Arthritis
- Entecavir (Baraclude) - Oral Antiviral Drug for Hepatitis-B Infection, United States of America
- Erbitux (Cetuximab)
- Erivedge (vismodegib) – Treatment for Advanced Basal Cell Carcinoma
- Erwinaze (Asparaginase Erwinia Chrysanthemi) - Treatment for ALL, United States of America
- ETC-216 - Phospholipid
- Eviplera – Treatment for HIV, United States of America
- Exanta - Oral Direct Thrombin Inhibitor for the
- Exjade (Deferasirox) for Treating Chronic Iron Overload, United States of America
- Exparel for Postsurgical Pain Relief
- Exubera - Inhaled Insulin
- Eylea (Aflibercept) for Treatment for Wet AMD, United States of America
- Fablyn (Lasofoxifene) - Investigational SERM
- Fampridine-SR – Treatment for Multiple Sclerosis
- Dificid (fidaxomicin) – Narrow-Spectrum Antibiotic for Clostridium Difficile Infection
- Fingolimod - Novel Therapy for Multiple Sclerosis
- FIRAZYR – Treatment for Hereditary Angioedema
- Florbetaben
- Flucelvax Vaccine for Protection Against Seasonal Influenza, United States of America
- Fludase - Experimental Antiviral Drug for Influenza
- FluLaval Influenza Virus Vaccine, United States of America
- Flurizan – Anti-Amyloid Drug for Treatment of Alzheimer’s Disease
- Flutiform (fluticasone proprionate and formoterol fumarate) for Treatment of Asthma, United Kingdom
- Forxiga (dapagliflozin) for Treatment of Type 2 Diabetes, Italy
- Fulyzaq (Crofelemer) for the Treatment of HIV / AIDS-Associated Diarrhoea, United States of America
- Fycompa (perampanel) – Treatment for Epilepsy, Japan
- Gaboxadol - Investigational Agent
- Galida - Dual PPAR
- Galvus (vildagliptin) - DPP-IV Inhibitor / Oral
- Gattex (Teduglutide) for Treatment of Short Bowel Syndrome (SBS), United States of America
- Glybera (alipogene tiparvovec) for Treatment of Lipoprotein Lipase Deficiency (LPLD), United States of America
- GRNOPC1 for spinal-cord injury, United States of America
- Iclusig (ponatinib) for the Treatment of Chronic Myeloid Leukaemia, United States of America
- Idraparinux - Investigational Agent for Treatment and Prevention of Thromboembolic Events
- Iloperidone - Atypical Antipsychotic for Schizophrenia
- Iluvien, United States of America
- INCB9471 – CCR5 Antagonist for Treatment of HIV Infection
- Incivek / Telaprevir - Treatment for Chronic Hepatitis C
- Indinavir – First-Generation HIV Protease Inhibitor
- Influenza A (H1N1) Monovalent Vaccine by Sanofi Pasteur
- Inspra (Eplerenone)
- Intermezzo – Treatment for Insomnia, United States of America
- Invokana (canagliflozin) for the Treatment of Type 2 Diabetes, United States of America
- Istaroxime
- Ixempra (Ixapebilone) – New Cancer Therapy
- Jakafi (ruxolitinib) - Treatment of Myelofibrosis, United States of America
- Januvia - DPP-IV inhibitor for Type 2 Diabetes
- Jetrea (ocriplasmin) for Treatment of Symptomatic Vitreomacular Adhesion, United States of America
- Juxtapid (lomitapide) for Treatment of Homozygous Familial Hypercholesterolemia (HoFH), United States of America
- Kadcyla (Trastuzumab Emtansine) for Treatment of Breast Cancer, United States of America
- Kalbitor - Treatment for Hereditary Angioedema
- Kalydeco (Ivacaftor) - Treatment for Cystic Fibrosis
- Kineret (anakinra) for the Treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID), United States of America
- Korlym (Mifepristone) for Treatment of Endogenous Cushing’s Syndrome, United States of America
- KRX-0401 (Perifosine)
- Kyprolis (carfilzomib) for Treatment of Multiple Myeloma, United States of America
- Lamictal – Approved Treatment for Epilepsy and Bipolar, United States of America
- Latuda (lurasidone HCl) for the Treatment of Schizophrenia, United States of America
- Lexapro
- Licofelone - Novel Analgesic and Anti-Inflammatory
- Linzess for the Treatment of Irritable Bowel Syndrome with Chronic Idiopathic Constipation, United States of America
- Lipitor (Atorvastatin) - Treatment for High Cholesterol, United States of America
- Liraglutide - Next-Generation Antidiabetic Medication
- Lixisenatide
- LODOTRA - Treatment for Rheumatoid Arthritis
- Lorcaserin, Investigational Oral Anti-Obesity Drug
- Lovenox (Enoxaparin Sodium) - Treatment for Deep Vein Thrombosis (DVT), United States of America
- Lucentis (ranibizumab) for the Treatment of Diabetic Macular Edema (DME), United States of America
- Lurasidone - Treatment for Schizophrenia and Bipolar Disorder, Japan
- LY2140023 – Treatment of Schizophrenia
- Lyrica (Pregabalin) - New Gabapentinoid with Wide
- M6G, A New Morphine Derivative For Post-Operative Pain Relief
- Maraviroc - Therapy for Treatment of HIV Infection
- Menactra - Meningococcal Vaccine, United States of America
- Menveo vaccine for the prevention of invasive meningococcal disease, United States of America
- Merck Isentress - Emerging Therapy for Treatment of HIV Infection
- Mirapex (Pramipexole) - Treatment for Parkinson's Disease, Germany
- MOR103 - Antibody for the Treatment of Rheumatoid Arthritis, Germany
- Motavizumab - New Biological Therapy for RSV Prevention
- Multaq
- Mylinax - Novel Therapy for the Treatment of
- Myrbetriq (Mirabegron) - Treatment for Overactive Bladder (OAB), Japan
- Naproxcinod (HCT 3012) - COX-Inhibiting Nitric Oxide-Donator
- Nesina (alogliptin) for Treatment of Type 2 Diabetes Mellitus, United States of America
- Nexavar – Oral Anti-Cancer Agent for Treatment of Liver and Kidney Cancer
- Nexium I.V.- Treatment of Gastroesophageal Reflux Disease, United States of America
- NG2-73 - A Novel Agent For The Treatment of Insomnia
- NicVAX for Nicotine Addiction, United States of America
- Novavax Trivalent VLP Vaccine for Seasonal Influenza
- Nulojix - Treatment for Preventing Acute Organ Rejection Post Kidney Transplantation
- Olcegepant - Novel Therapy for Acute Migraine
- Omontys (peginesatide) – for Treatment of Anaemia Associated with Chronic Kidney Disease
- Onbrez Capsules - Treatment for Chronic Obstructive Pulmonary Disease
- Onfi (Clobazam) - Treatment for Lennox-Gastaut Syndrome, United States of America
- Oral-Lyn - Oral Insulin for Type 1 and 2 Diabetes
- Oritavancin - Glycopeptide Antibiotic
- Oxtellar XR for the Treatment of Partial Seizures, United States of America
- Oxytrol (oxybutynin) for the Treatment of Overactive Bladder (OAB) in Women, United States of America
- Pandemrix - Adjuvanted H1N1 Influenza Vaccine
- Panflu.1 – Single-Shot Vaccine Against H1N1 Influenza
- Paxil – SSRI for the Treatment of Major Depressive Disorders, United States of America
- Pertuzumab – Treatment / Therapy for Breast Cancer
- Phenserine - Next Generation AChE Inhibitor
- Pirfenidone – Treatment for Idiopathic Pulmonary Fibrosis
- Plavix (Clopidogrel Bisulfate) - Treatment for Acute Coronary Syndrome, United States of America
- Plectasin NZ2114 - Novel Microbial Agent
- Pomalyst (Pomalidomide) for the Treatment of Multiple Myeloma, United States of America
- Pradaxa – Oral Direct Thrombin Inhibitor
- Prasugrel - Investigational Antiplatelet Agent
- Prexige - COX-2 Inhibitor
- Prolia (Denosumab) - Therapy for Prevention and Treatment of Osteoporosis
- Provenge - Treatment for Advanced Prostate Cancer
- PSI-7977 for Treatment of Chronic Hepatitis C, United States of America
- Rapiacta (peramivir) - Neuraminidase Inhibitor for Treatment of Influenza
- Rasagiline - Second-Generation MAO-B Inhibitor
- Rasilez
- Ravicti (glycerol phenylbutyrate) for Treatment of Urea Cycle Disorders (UCD), United States of America
- Rember
- Restanza
- Revatio (Sildenafil) - Treatment for Pulmonary Arterial Hypertension, United States of America
- Rezular – Oral Treatment for IBS
- RiaSTAP - Treatment for Congenital Fibrinogen Deficiency (CFD), United States of America
- Rifapentine
- Rituxan (Rituximab)
- Rupintrivir -
- Sabril (Vigabatrin) - Treatment for Refractory Complex Partial Seizures and IS, United States of America
- Sativex - Investigational Cannabis-Based treatment for Pain and Multiple Sclerosis
- Saxagliptin – Treatment for Type 2 Diabetes
- Selincro (nalmefene) - Treatment for Alcohol Dependence, Finland
- Semagacestat – Gamma Secretase Inhibitor for Alzheimer's Disease
- Seroquel - Treatment for Major Depressive Disorder (MDD)
- SF1126 -
- Signifor (Pasireotide) - Treatment for Cushing’s Disease, Germany
- Silenor (doxepin) for the Treatment of Insomnia, United States of America
- Simbrinza (brinzolamide/brimonidine tartrate) for the Reduction of Elevated Intraocular Pressure, United States of America
- Sirturo (bedaquiline) for Treatment of Pulmonary Multi-Drug Resistant Tuberculosis (TB), United States of America
- Soliris - Treatment for PNH and aHUS
- Spiriva – Treatment for Chronic Obstructive Pulmonary Disease, United States of America
- Stimuvax - Investigational Therapeutic Cancer Vaccine
- Stivarga (Regorafenib) for Treating Metastatic Colorectal Cancer (mCRC), United States of America
- Stribild – A Single Tablet Regimen for the Treatment of HIV-1, United States of America
- Surfaxin (Lucinactant) - Treatment for Preventing Infant RDS, United States of America
- Sutent (Sunitinib Malate) - Treatment for Pancreatic Neuroendocrine Tumours, United States of America
- Sycrest (asenapine) - Treatment for Bipolar I Disorder, United States of America
- Synribo (Omacetaxine Mepesuccinate) for Treating Chronic Myeloid Leukaemia, United States of America
- T-705 - Antiviral Drug for Influenza
- Tamiflu - Oral Anti-Viral Treatment Agent
- Taranabant
- Tarceva - Small Molecule
- Tasigna (Nilotinib), United States of America
- TB-402- Treatment of VTE and AF
- Telbivudine - Investigational Drug
- Tesmilifene - Chemopotentiator for Cancer
- Tesofensine Anti-Obesity Medication
- Tradjenta - Treatment for Type II Diabetes
- TRA-SCH-530348
- Trastuzumab -, United States of America
- Treximet - Next-Generation Treatment for Migraine
- Trobalt / Potiga – Treatment for Partial-Onset Seizure
- Truvada - Antiretroviral Treatment to Prevent HIV, United States of America
- Tudorza™ Pressair™ (aclidinium bromide inhalation powder) for Long-term Treatment of COPD, United States of America
- Tygacil - Broad-Spectrum Antibiotic for Empiric
- Tykerb - Dual Tyrosine Kinase Inhibitor
- Tysabri - Therapeutic Monoclonal Antibody (MAb)
- V1512 - Treatment of Parkinson's Disease
- Valtorcitabine - Combination Drug Therapy for Chronic Hepatitis B
- VariZIG (Varicella Zoster Immune Globulin Human) for Treating Chickenpox, Canada
- Veletri (epoprostenol) for the Treatment of Pulmonary Arterial Hypertension (PAH), United States of America
- Vesicare - Oral Selective Muscarinic Receptor
- Viibryd - Treatment for Major Depressive Disorder, United States of America
- Voraxaze (glucarpidase) for the Treatment of Toxic Plasma Methotrexate Concentrations, United States of America
- Voreloxin, Anti-Cancer Quinolone Derivative, United States of America
- Vosaroxin - Treatment for Myeloid Leukaemia, United States of America
- Votrient - Treatment for Renal Cell Cancer and Soft Tissue Sarcoma, United States of America
- Vyndaqel (Tafamidis) - Treatment for Transthyretin Familial Amyloid Polyneuropathy
- Xalkori - Treatment for Non-Small Cell Lung Cancer
- Xarelto: Investigational Agent for Treatment and Prevention of Thromboembolic Events
- Xeljanz (tofacitinib) - Treatment for Rheumatoid Arthritis, United States of America
- Xeloda – Treatment for Metastatic Colorectal Cancer, United States of America
- Xgeva (Denosumab) for the Prevention of Metastatic Bone Cancer, United States of America
- Xiaflex to Treat Dupuytren's Contracture, United States of America
- Xolair - Biological Therapy
- Xtandi (enzalutamide) for Treatment of Metastatic Castration-Resistant Prostate Cancer, United States of America
- Zactima - Tyrosine Kinase Inhibitor
- Zaltrap (ziv-aflibercept) for the Treatment of Metastatic Colorectal Cancer, United States of America
- Zegerid – Proton Pump Inhibitor for Treatment of Heartburn
- Zelboraf (vemurafenib) Tablets – Treatment for Metastatic Melanoma
- Zinforo (ceftaroline fosamil) for the Treatment of Complicated Skin and Soft Tissue Infections, United Kingdom
- Zioptan for the Reduction of Elevated Intraocular Pressure (IOP), United States of America
- Zohydro (Hydrocodone Bitartrate) for the Treatment of Chronic Pain, United States of America
- Zometa for Preventing Bone Cancer Complications, United States of America
- Zybrestat - Vascular Disrupting Agent and Cancer Therapy
- Zyprexa – Antipsychotic for the Treatment of Schizophrenia, Psychotic and Bipolar Disorders
- Zytiga (abiraterone acetate) - Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC), United States of America
Twitter
Facebook